References
- Dolff S, Berden JH, Bijl M. Treatment of lupus nephritis. Expert Rev Clin Immunol. 2010;6:901–911.
- Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241–250.
- Kraft SW, Schwartz MM, Korbet SM, et al. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol. 2005;16:175–179.
- Han TS, Schwartz MM, Lewis EJ. Association of glomerular podocytopathy and nephritic proteinuria in mesangial lupus nephritis. Lupus. 2006;15:71–75.
- D’Agati VD. The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens. 2008;17:271–281.
- Mizushima N. Autophagy: process and function. Genes Dev. 2007;21:2861–2873.
- Kung CP, Budina A, Balaburski G, et al. Autophagy in tumor suppression and cancer therapy. Crit Rev Eukaryot Gene Expr. 2011;21:71–100.
- Santos RX, Cardoso S, Correia S, et al. Targeting autophagy in the brain: a promising approach? Cent Nerv Syst Agents Med Chem. 2010;10:158–168.
- Hartleben B, Godel M, Meyer-Schwesinger C, et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest. 2010;120:1084–1096.
- Kume S, Uzu T, Horiike K, et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest. 2010;120:1043–1055.
- Cinà DP, Onay T, Paltoo A, et al. Inhibition of MTOR disrupts autophagic flux in podocytes. J Am Soc Nephrol. 2012;23:412–420.
- Wu L, Feng Z, Cui S, et al. Rapamycin upregulates autophagy by inhibiting the mTOR–ULK1 pathway, resulting in reduced podocyte injury. PLoS One. 2013;8:e63799.
- Sato S, Yanagihara T, Ghazizadeh M, et al. Correlation of autophagy type in podocytes with histopathological diagnosis of IgA nephropathy. Pathobiology. 2009;76:221–226.
- Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol. 2010;12:823–830.
- Sato S, Kitamura H, Adachi A, et al. Two types of autophagy in the podocytes in renal biopsy specimens: ultrastructural study. J Submicrosc Cytol Pathol. 2006;38:167–174.
- Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8:445–544.
- Zheng CX, Chen ZH, Zeng CH, et al. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro. Kidney Int. 2008;74:596–612.
- Zeng C, Fan Y, Wu J, et al. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies. J Pathol. 2014;234:203–213.
- Kurahashi T, Miyake H, Hara I, et al. Expression of major heat shock proteins in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. J Urol. 2007;177:757–761.
- Jiang S, Li Y, Zhu YH, et al. Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma. Cancer Sci. 2011;102:1568–1575.
- Kim KM, Yu TK, Chu HH, et al. Expression of ER stress and autophagy-related molecules in human non-small cell lung cancer and premalignant lesions. Int J Cancer. 2012;131:362–370.
- Asanuma K, Tanida I, Shirato I, et al. MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J. 2003;17:1165–1167.
- Mizushima N, Komatsu M. Autophagy: Renovation of cells and tissues. Cell. 2011;147:728–741.